Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer
W. B. Growdon, E. Lopez-Varela, R. Littell, E. Oliva, M. Seiden, C. Krasner, H. Lee, A. Fuller
International Journal of Gynecologic Cancer Feb 2008, 18 (2) 262-268; DOI: 10.1111/j.1525-1438.2007.01011.x
